Combination Therapy with Zidovudine Prevents Selection of Human Immunodeficiency Virus Type 1 Variants Expressing High-Level Resistance to L-697,661, a Nonnucleoside Reverse Transcriptase Inhibitor

Autor:	Staszewski, S., Massari, F. E., Kober, A., Göhler, R., Durr, S., Anderson, K. W., Schneider, C. L., Waterbury, J. A., Bakshi, K. K., Taylor, V. I., Hildebrand, C. S., Kreisl, C., Hoffstedt, B., Schleif, W. A., von Briesen, H., Rübsamen-Waigmann, H., Calandra, G. B., Ryan, J. L., Stille, W., Emini, E. A., Byrnes, V. W.
Zdroj:	The Journal of Infectious Diseases, 1995 May 01. 171(5), 1159-1165.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/30134542 Zobrazit plný text záznamu